B-Temia’s Keeogo system (Image from B-Temia)
B-Temia announced today that it received FDA 510(k) clearance for its Keeogo Dermoskeleton human mobility system.
Short for “keep on going,” Keeogo is a lower-limb-powered human mobility device with Dermoskeleton lightweight exoskeleton technology that provides what the Quebec City-based company describes in a news release as a “true human-machine interface.”
The Keeogo Dermoskeleton is designed to detect, respond to and support an individual’s movements with advanced software and motorized assistance. Based on individual needs, it offers mobility assistance, including complimentary knee strength and movement cues.
B-Temia’s system is intended for use by stroke patients who fit the user assessment criteria in rehabilitation settings under the supervision of healthcare professionals.
“The work we …